Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
US Market
Holding LIPO?
Track your performance easily

Lipella Pharmaceuticals, Inc. (LIPO) Financial Statements

40 Followers

Lipella Pharmaceuticals, Inc. Financial Overview

Lipella Pharmaceuticals, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.63; its P/E ratio is -0.82; Lipella Pharmaceuticals, Inc. is scheduled to report earnings on May 15, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 136.43K$ 145.88K$ 449.62K$ 104.05K$ 106.68K
Gross Profit$ 136.43K$ 145.88K$ -4.58K$ 104.05K$ 106.68K
EBIT$ -938.15K$ -1.19M$ -688.88K$ -1.32M$ -1.53M
EBITDA$ -936.77K$ -1.19M$ -688.16K$ -1.32M$ -1.53M
Net Income Common Stockholders$ -938.15K$ -1.19M$ -688.88K$ -1.32M$ -1.54M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.19M$ 2.11M$ 3.29M$ 2.41M$ 3.11M
Total Assets$ 2.18M$ 3.14M$ 3.58M$ 2.84M$ 3.49M
Total Debt$ 93.68K$ 115.70K$ 136.59K$ 157.76K$ 126.18K
Net Debt$ -1.09M$ -1.99M$ -3.16M$ -2.25M$ -2.99M
Total Liabilities$ 480.31K$ 575.88K$ 432.73K$ 619.21K$ 364.19K
Stockholders Equity$ 1.70M$ 2.56M$ 3.14M$ 2.22M$ 3.13M
Cash Flow-
Free Cash Flow$ -918.79K$ -1.39M$ -727.71K$ -703.80K$ -655.11K
Operating Cash Flow$ -918.79K$ -1.39M$ -727.71K$ -689.36K$ -655.11K
Investing Cash Flow---$ -14.43K-
Financing Cash Flow-$ 200.00K$ 1.61M-$ -250.00K
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

Lipella Pharmaceuticals, Inc. Debt to Assets

Lipella Pharmaceuticals, Inc. Cash Flow

Lipella Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis